ARMO BioSciences

General Information

We are a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary product candidates that activate the immune system of cancer patients to recognize and eradicate tumors. Our vision is to improve and prolong the lives of cancer patients by advancing and expanding the field of immuno-oncology through novel combinations and treatment sequences of our pipeline products with standard of care chemotherapies and checkpoint inhibitors or with other emerging immunotherapies that elicit complementary and synergistic treatment effects.


Employees: 21
Founded: 2010
Contact Information
Address 575 Chesapeake Drive, Redwood City, CA 94063, US
Phone Number (650) 779-5075
Web Address
View Prospectus: ARMO BioSciences
Financial Information
Market Cap $497.7mil
Revenues $0 mil (last 12 months)
Net Income $-39.6 mil (last 12 months)
IPO Profile
Symbol ARMO
Exchange NASDAQ
Shares (millions): 7.5
Price range $17.00 - $17.00
Est. $ Volume $128.0 mil
Manager / Joint Managers Jefferies/ Leerink Partners/ BMO Capital Markets
CO-Managers Baird
Expected To Trade: 1/26/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change